Wells Fargo’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8K | Sell |
4,986
-420
| -8% | -$1.33K | ﹤0.01% | 5392 |
|
|
2025
Q1 | $19.1K | Buy |
5,406
+798
| +17% | +$2.83K | ﹤0.01% | 5270 |
|
|
2024
Q4 | $14.7K | Sell |
4,608
-3,400
| -42% | -$10.8K | ﹤0.01% | 5342 |
|
|
2024
Q3 | $29.4K | Buy |
8,008
+950
| +13% | +$3.49K | ﹤0.01% | 5127 |
|
|
2024
Q2 | $33K | Sell |
7,058
-558
| -7% | -$2.61K | ﹤0.01% | 5068 |
|
|
2024
Q1 | $67K | Buy |
7,616
+3,121
| +69% | +$27.5K | ﹤0.01% | 4756 |
|
|
2023
Q4 | $19.2K | Buy |
4,495
+3
| +0.1% | +$13 | ﹤0.01% | 5212 |
|
|
2023
Q3 | $15.3K | Buy |
4,492
+4
| +0.1% | +$14 | ﹤0.01% | 5321 |
|
|
2023
Q2 | $25.3K | Buy |
4,488
+2
| +0% | +$11 | ﹤0.01% | 5376 |
|
|
2023
Q1 | $21.7K | Buy |
4,486
+501
| +13% | +$2.42K | ﹤0.01% | 5293 |
|
|
2022
Q4 | $24.1K | Buy |
3,985
+1
| +0% | +$6 | ﹤0.01% | 4870 |
|
|
2022
Q3 | $19K | Buy |
3,984
+204
| +5% | +$973 | ﹤0.01% | 5098 |
|
|
2022
Q2 | $21K | Buy |
3,780
+222
| +6% | +$1.23K | ﹤0.01% | 5135 |
|
|
2022
Q1 | $25K | Buy |
3,558
+2,326
| +189% | +$16.3K | ﹤0.01% | 5598 |
|
|
2021
Q4 | $9K | Buy |
1,232
+279
| +29% | +$2.04K | ﹤0.01% | 6042 |
|
|
2021
Q3 | $11K | Sell |
953
-6,470
| -87% | -$74.7K | ﹤0.01% | 5844 |
|
|
2021
Q2 | $109K | Buy |
7,423
+3,780
| +104% | +$55.5K | ﹤0.01% | 4969 |
|
|
2021
Q1 | $66K | Buy |
3,643
+3,575
| +5,257% | +$64.8K | ﹤0.01% | 5330 |
|
|
2020
Q4 | $1K | Buy |
68
+57
| +518% | +$838 | ﹤0.01% | 6017 |
|
|
2020
Q3 | $0 | Buy |
+11
| New | – | ﹤0.01% | 6249 |
|